Introduction {#S1}
============

Hematologic abnormalities appeared to be the main cause of ischemic stroke in approximately one percent of all cases, and derangement of the coagulation process in young people with stroke has been estimated to be about four percent.^[@R1]^ The most studied factors in the coagulation process are anticardiolipin antibodies (ACA), which have been recognized as markers for an increased risk of thrombosis, and cerebral ischemia.^[@R2]^ Previously we have shown an association between protein S deficiency and elevated ACA.^[@R3]^ D-dimer levels in plasma, a degradation product of fibrin, have been shown to correlate with severity of ischemic stroke^[@R4]^ and clinical progression.^[@R5]^ We prospectively investigated all acute stroke patients of 65 years of age and younger admitted to our stroke unit between 1991 and 1992 for traditional risk factors and D-dimer. In order to study the outcome and long-term follow-up a questionnaire concerning cerebro- or cardioischemic events was sent to all patients during spring 2004 (n=42). Patients not responding to the written questionnaire were contacted by phone. In addition, the medical records from the departments of Neurology and Internal Medicine were checked for all patients.

Materials and Methods {#S2}
=====================

Patients
--------

With the approval for this study by the ethics committee of Linköping University Hospital, 502 patients, who were admitted to our stroke unit for suspected acute stroke during 1991 to 1992, were investigated for the presence of ACA.^[@R6]^ Three hundred and ninety-four of the 502 patients of all age groups had ischemic stroke or transient ischemic attacks (TIA). In 66 patients of 65 years of age or younger ACA, protein C and S, free protein S, and ATIII were analysed.^[@R3]^ In 57 of these 66 patients (36 men and 21 women, mean age 51.4 yr, range 24--64 yr), D-dimer was measured as well. Blood samples were taken within 24 hours of admission in the patients. All patients underwent computed tomography of the brain to establish diagnosis. Strokes were classified on the basis of the presence of risk factors, the mode of onset, clinical findings, and the nature and location of the occluded vessel according to Berger *et al.*^[@R7]^ (cardioembolic: n=11, atherothrombotic: n=11, lacunar: n=19, TIA: n=11, unknown: n=5). In addition, previous stroke, myocardial infarction, and peripheral thrombosis were noted. Symptoms and laboratory signs of infection were recorded. Platelet count, activated partial tromboplastin time (APTT), sedimentation rate (SR), C-reactive protein (CRP), and white blood cell count were measured in all patients. Risk factors were scrutinized in each patient. Carotid Doppler was performed in 49 patients. Triglycerides and cholesterol were examined in 50 patients.

Laboratory methods
------------------

D-dimer was measured utilizing an automated micro-latex assay, Tina-quant®, from Boehringer-Mannheim (Darmstadt, Germany) using a Hitachi 911 analyzer, manufactured by Hitachi (Kobe, Japan). Normal values were \<0.15 mg/mL, which was the lower detection limit.

Statistical methods
-------------------

Student's *t*-test was used for analyses of D-dimer levels in relation to the type of stroke. The χ^2^-test was used to compare groups of patients with elevated or normal D-dimer levels. A multivariate logistic regression analysis was used to compare risk factors in patients with later cerebro- or cardiovascular events compared to patients without later events. A *p*-value of ≤0.05 was judged as significant.

Results {#S3}
=======

Elevated D-dimer levels were found in 22 of the 57 patients (mean 0.41 mg/mL, range 0.15--2.02) ([Table 1](#T1){ref-type="table"}). One of the patients had a previous TIA and one a myocardial infarction. Three patients were found to have a carotid stenosis of ≥75% and two a carotid occlusion. We found significantly elevated D-dimer levels in cardioembolic stroke as compared to atherothrombotic and lacunar stroke ([Figure 1](#F1){ref-type="fig"}). There were more patients with a major than a minor stroke in the group with elevated D-dimer levels (9/13) compared to the group with normal D-dimer levels (8/27), although this difference was not statistically significant (*p*=0.15, χ^2^-test) ([Table 1](#T1){ref-type="table"}). The mean value for patients with major stroke was 0.47 mg/mL (range 0.15--2.02) compared to patients with minor stroke: 0.36 mg/mL (range 0.16--1.42), not a statistically significant difference. On follow-up after a mean of 12 years, 15 patients had died (seven from cardiovascular events, three from pneumonia, two from cancer, one after a pulmonary embolus, one from amyloidosis, and one from multi-organ failure). Five patients had suffered another ischemic stroke (three of whom were dead) and one had suffered a TIA. Ten had suffered other cardiovascular events (myocardial infarction, angina, congestive heart failure, aortic aneurysm), seven of them were dead ([Figure 2](#F2){ref-type="fig"}).

Table 1Characteristics of patients with elevated and normal D-dimer levels.Patient groupNumber and sex (male/female)Age, years (mean and range)Atrial fibrillationDiabetes mellitusHypertensionCarotid Doppler (stenosis ≥75% or occlusionMajor/minor strokeSubtype of stroke (number of patients)Infectious parameters (number of elevated tests)Elevated D-dimer levels22 (14/8)52.3 (30--65)02659/13cardioembolic 4 atherothrombotic 7 lacunar 8 unknown 1 TIA 2SR 7 CRP 3 WBC 8Normal D-dimer levels35 (21/14)52.3 (25--65)341108/27cardioembolic 7 atherothrombotic 4 lacunar 11 unknown 4 TIA 9SR 5 CRP 4 WBC 8[^1]

Figure 1D-dimer levels in relation to stroke subtypes.

Figure 2Kaplan-Meyer graph of cerebro- and cardiovascular events during follow-up. MI: myocardial infarction; CI: cerebral infarction; TIA: transitory ischemic attack; †: dead.

There was a trend for patients with elevated levels of D-dimer at the time of sampling after the stroke to be more prone to develop further cardio- or cerebrovascular events at follow-up (eight of 22 patients compared to seven of 35 of those with normal D-dimer levels; *p*=0.17, χ^2^-test and Pearson's correction). Mean values were slightly higher for patients who had further cardio- and cerebrovascular events: 0.47 mg/mL (range 0.19--1.42) compared to 0.37 mg/mL (range 0.15--2.02) for those without further events during follow-up. When using a multivariate analysis with logistic regression, however, this variable was not an independent risk factor (odds ratio 2.5, *p*=0.19). The 15 patients with later cerebro- or cardiovascular events were significantly older: 60.4 years compared to the 42 patients without later events aged 49.5 years (odds ratio 1.2,*p*=0.01). Other risk factors (cardiac arrhythmia, diabetes, high blood pressure, carotid stenosis, smoking, high cholesterol, previous TIA or stroke, or angina) were not independently correlated to later cerebro- or cardiovascular events.

Discussion {#S4}
==========

We found an association between elevated D-dimer levels and cardioembolic stroke, which was in agreement with reports of other researchers.^[@R4],[@R8]^ Elevated levels in patients with acute ischemic stroke have been found for up to four weeks in some persons.^[@R9]^ In addition, plasma concentrations of D-dimer have been reported to be an indicator of recurrent embolization in patients suffering from cardioembolic stroke.^[@R10]^ A trend toward an increased risk of recurrent cardio- and cerebrovascular events on follow-up after a mean of 12 years in patients with elevated D-dimer levels was noted (eight of 22 patients compared to seven of 35 with normal D-dimer levels); however, the difference was not statistically significant (*p*=0.17). Patients with high D-dimer, fibrinogen, and CRP have been associated with an increased risk of recurrent cardiovascular events,^[@R11]^ which was found in our patients with elevated D-dimer levels (10 had suffered cardiovascular events on follow-up).

In a review, Lowe (2005)^[@R12]^ discussed the potential clinical utility of D-dimer testing in the prediction of cardiovascular risk and prophylactic anticoagulation. In addition, D-dimer levels have been shown to predict clinical progression in ischemic stroke.^[@R5]^ There are further reports showing no relationship between D-dimer levels and recurrent ischemic stroke.^[@R13],[@R14]^ Woodward *et al.*,^[@R14]^ however, found that fibrinogen and CRP were risk factors for recurrent ischemic stroke. The severity of the recurrent events in our patients is evident because five of the eight patients died. D-dimer levels were found to be related linearly to stroke severity in 76 consecutive ischemic stroke patients.^[@R15]^ Moreover, D-dimer is reported to be a good predictor for identifying patients at high risk for stroke progression, supporting our observation of a severe course for many of the patients with elevated D-dimer levels.^[@R5]^ Patients with atrial fibrillation and elevated D-dimer levels are reported to be more prone to develop thromboembolic events.^[@R16]^ This conclusion is disputed by others.^[@R17]^ In our patients with elevated D-dimer levels, none of them had atrial fibrillation. However, high-grade carotid stenosis (≥75%) or carotid occlusion was found in five of our patients with elevated D-dimer levels. We concluded that high levels of D-dimer in patients with acute ischemic stroke are associated with cardioembolic stroke and may have a pathogenetic importance for development of further cardio- or cerebrovascular events. Advanced age seems to be an important independent risk factor for further cerebro- or cardiovascular events. Because there were relatively few patients in our study, its prognostic role remains somewhat uncertain and, as suggested by Squizzato *et al.*^[@R18]^ further larger studies are warranted.

Mats Fredriksson for statistical help.

[^1]: SR: sedimentation rate (n\<20 mm for men and \<12 mm for women), CRP: C-reactive protein (n\<10), WBC: white blood cell count (n\<10×10^9^/L).
